<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101525337</journal-id>
<journal-id journal-id-type="pubmed-jr-id">37346</journal-id>
<journal-id journal-id-type="nlm-ta">ACS Chem Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">ACS Chem Neurosci</journal-id>
<journal-title-group>
<journal-title>ACS chemical neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1948-7193</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29359916</article-id>
<article-id pub-id-type="pmc">6033619</article-id>
<article-id pub-id-type="doi">10.1021/acschemneuro.7b00399</article-id>
<article-id pub-id-type="manuscript">NIHMS975439</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Functional Modulation of Voltage-Gated Sodium Channels by a FGF14-Based Peptidomimetic</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ali</surname>
<given-names>Syed R.</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
<xref ref-type="author-notes" rid="FN2">○</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Zhiqing</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nenov</surname>
<given-names>Miroslav N.</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Folorunso</surname>
<given-names>Oluwarotimi</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Singh</surname>
<given-names>Aditya</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scala</surname>
<given-names>Federico</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Haiying</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>James</surname>
<given-names>T. F.</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Alshammari</surname>
<given-names>Musaad</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
<xref ref-type="aff" rid="A6">▽</xref>
<xref ref-type="author-notes" rid="FN3">◆</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Panova-Elektronova</surname>
<given-names>Neli I.</given-names>
</name>
<xref ref-type="aff" rid="A1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>White</surname>
<given-names>Mark Andrew</given-names>
</name>
<xref ref-type="aff" rid="A2">‡</xref>
<xref ref-type="aff" rid="A3">§</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhou</surname>
<given-names>Jia</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
<xref ref-type="aff" rid="A1">†</xref>
<xref ref-type="aff" rid="A4">||</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Laezza</surname>
<given-names>Fernanda</given-names>
</name>
<xref ref-type="author-notes" rid="FN1">*</xref>
<xref ref-type="aff" rid="A1">†</xref>
<xref ref-type="aff" rid="A4">||</xref>
<xref ref-type="aff" rid="A5">⊥</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>†</label>Department of Pharmacology &amp; Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</aff>
<aff id="A2">
<label>‡</label>Sealy Center for Structural Biology &amp; Molecular Biophysics, University of Texas Medical Branch, Galveston, Texas 77555, United States</aff>
<aff id="A3">
<label>§</label>Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas 77555, United States</aff>
<aff id="A4">
<label>||</label>Center for Addiction Research, University of Texas Medical Branch, Galveston, Texas 77555, United States</aff>
<aff id="A5">
<label>⊥</label>Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas 77555, United States</aff>
<aff id="A6">
<label>▽</label>King Saud University Graduate Studies Abroad Program, King Saud University, Riyadh, Saudi Arabia</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Authors: For medicinal chemistry (J.Z.): Mailing address: Department of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA. <email>jizhou@utmb.edu</email>. For biophysics and neurobiology (F.L.): Mailing address: Department of Pharmacology and Toxicology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555, USA. <email>felaezza@utmb.edu</email></corresp>
<fn fn-type="present-address" id="FN2">
<label>○</label>
<p><bold>Present Addresses:</bold> Department of Pharmacology, Yale University, New Haven, CT 06510, United States (S.R.A.).</p>
</fn>
<fn fn-type="present-address" id="FN3">
<label>◆</label>
<p><bold>Present Addresses:</bold> Department of Pharmacology &amp; Toxicology, King Saud University, Riyadh, Saudi Arabia (M.A.).</p>
</fn>
<fn id="FN4">
<p>
<bold>ORCID</bold>
</p>
<p>Syed R. Ali: 0000-0001-7802-4713</p>
<p>Jia Zhou: 0000-0002-2811-1090</p>
</fn>
<fn fn-type="COI-statement" id="FN6">
<p>The authors declare no competing financial interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>16</day>
<month>6</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>06</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<day>16</day>
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>16</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>9</volume>
<issue>5</issue>
<fpage>976</fpage>
<lpage>987</lpage>
<!--elocation-id from pubmed: 10.1021/acschemneuro.7b00399-->
<abstract id="Abs1">
<p id="P1">Protein–protein interactions (PPI) offer unexploited opportunities for CNS drug discovery and neurochemical probe development. Here, we present ZL181, a novel peptidomimetic targeting the PPI interface of the voltage-gated Na<sup>+</sup> channel Nav1.6 and its regulatory protein fibroblast growth factor 14 (FGF14). ZL181 binds to FGF14 and inhibits its interaction with the Nav1.6 channel C-tail. In HEK-Nav1.6 expressing cells, ZL181 acts synergistically with FGF14 to suppress Nav1.6 current density and to slow kinetics of fast inactivation, but antagonizes FGF14 modulation of steady-state inactivation that is regulated by the N-terminal tail of the protein. In medium spiny neurons in the nucleus accumbens, ZL181 suppresses excitability by a mechanism that is dependent upon expression of FGF14 and is consistent with a state-dependent inhibition of FGF14. Overall, ZL181 and derivatives could lay the ground for developing allosteric modulators of Nav channels that are of interest for a broad range of CNS disorders.</p>
</abstract>
<abstract abstract-type="graphical" id="Abs2">
<title>Graphical Abstract</title>
<p id="P2">
<graphic orientation="portrait" position="anchor" xlink:href="nihms975439u1.jpg"></graphic></p>
</abstract>
<kwd-group>
<kwd>Fibroblast growth factor 14 (FGF14)</kwd>
<kwd>protein:protein interaction (PPI)</kwd>
<kwd>voltage-gated sodium channels (Nav1.6)</kwd>
<kwd>peptidomimetics</kwd>
<kwd>minimal functional domains</kwd>
<kwd>neurochemical probes</kwd>
<kwd>CNS drug discovery</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>